glp-1 semaglutide side effects POTD: Wegovy and Ozempic — Maimonides Emergency Medicine Residency What Should I Expect During
Description
Trial data showed 21.1% weight loss at 8mg versus 24.2% at 12mg
Semaglutide works by mimicking a natural hormone that controls blood sugar and appetite, leading to measurable reductions in A1C levels within 812 weeks of treatment
11 However, evidence suggests that when IMD therapy is accompanied by supervised exercise, those adverse effects occurring after treatment discontinuation can be attenuated
Terns Pharmaceuticals reports topline 12-week data from its phase 2 trial evaluating oral GLP-1 receptor agonist TERN-601 in obesity
